Cannara Biotech Inc.

TSXV LOVE.V

Cannara Biotech Inc. Debt to Equity Ratio for the year ending August 31, 2024: 0.55

Cannara Biotech Inc. Debt to Equity Ratio is 0.55 for the year ending August 31, 2024, a -4.30% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Cannara Biotech Inc. Debt to Equity Ratio for the year ending August 31, 2023 was 0.57, a -20.82% change year over year.
  • Cannara Biotech Inc. Debt to Equity Ratio for the year ending August 31, 2022 was 0.73, a 122.48% change year over year.
  • Cannara Biotech Inc. Debt to Equity Ratio for the year ending August 31, 2021 was 0.33, a -3.33% change year over year.
  • Cannara Biotech Inc. Debt to Equity Ratio for the year ending August 31, 2020 was 0.34, a 20.25% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
SV Wall Street
TSXV: LOVE.V

Cannara Biotech Inc.

CEO Mr. Zohar Krivorot
IPO Date Jan. 14, 2019
Location Canada
Headquarters 333 Decarie Blvd.
Employees 461
Sector Consumers Staples
Industries
Tobacco Alcoholic Beverages Bread & Bakery Cosmetics Drugstores & Retail Pharmacies Perfumes & Fragrances Personal Care
Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

StockViz Staff

February 6, 2025

Any question? Send us an email